Latest news about signalling science and CIBSS scientists
Prof. Dr. Claudia Jessen-Trefzer appointed Professor of Pharmaceutical Biology and Biotechnology
On 1 April 2025, CIBSS researcher Prof. Dr. Claudia Jessen-Trefzer was appointed Professor of Pharmaceutical Biology and Biotechnology.
MoreFeaturing NextGen Signalling Scientists
CIBSS has launched a new series of interviews with early career researchers focused on signalling research in Freiburg.
MoreHow a flexible protein domain links gene transcription and RNA processing
Dr. Tanja Bhuiyan and a team of researchers from the University of Freiburg discover a mechanism that offers new insight into the inner workings of gene regulation.
MoreFrom one to the right
Chromatin enzymes play a crucial role in germ layer formation at the onset of zygotic genome activation in Drosophila embryos.
MoreFreiburg cancer researcher receives German Cancer Prize 2025
CIBSS researcher Prof. Dr. Dr. Melanie Börries from the University Medical Center Freiburg is honoured for her pioneering work on personalised cancer therapy
MoreWorld Health Day 2025: Progress through research and prevention
Medical research enables new diagnostics and therapies. Patients benefit from this, both in the case of common diseases and rare diseases
MoreHealthy Beginnings, Hopeful Futures
How Biomedical Research Uncovers the Mechanisms Behind Rare Genetic Diseases and offers hope for novel therapies
MoreSignalling research: Innovation for medicine & plants
Lectins play a key role in cell communication across diverse organisms. CIBSS researchers explore their functions to advance medicine, agriculture, and biotechnology.
MoreRecap: Tri-Regio AI Networking Symposium (TRAIN) 2025
On 17 March 2025, the TRAIN Symposium organized by CIBSS united AI researchers, computational scientists, and data experts in Freiburg to foster interdisciplinary collaboration and advance AI research.
MoreGloBIAS seminar series – Image analysis using Galaxy
Galaxy Image Analysis was presented at the GloBIAS seminar series
More